Clinically Proven Stress Reduction Method: Vagus Nerve Stimulation Device Update

Pulsetto has updated its FCC-certified vagus nerve stimulation device, which is clinically proven to reduce stress levels, thus mitigating the long-term negative physical and mental impacts of stress.

Vilnius, Lithuania - June 28, 2024 —

The newly updated vagus nerve stimulation device is designed to be worn around the back of the neck, where it sends subtle electrical pulses into the vagus nerve. This action signals the parasympathetic nervous system to override the sympathetic nervous system, delivering users' bodies and minds into a more relaxed state, within minutes. Pulsetto's vagus nerve stimulation device is thus an effective method for increasing resilience to stress and reducing the negative effects it can have over time.

More details can be found by visiting https://pulsetto.tech/products/meet-pulsetto

As an article from the Mayo Clinic explains, chronic stress keeps the body in constant "fight or flight" mode, which means it is overexposed to cortisol and other stress hormones. This increases the risk for a range of health problems, including heart disease, high blood pressure, stroke, depression, anxiety, insomnia, digestive disorders, unwanted weight gain, and more. Pulsetto's vagus nerve stimulation device moves the body out of "fight or flight" mode and into "rest and digest" mode, in which calming neurotransmitters like serotonin and acetylcholine are released and the body's stress hormones are returned to healthy levels.

Recent clinical studies have revealed that vagus nerve stimulation led to a 64.5% increase in heart rate variability (HRV), a measure of the variation in the time intervals between a person's heartbeat. Higher HRV is associated with a decreased stress response, greater resilience to stress, lower anxiety levels, and a generally happier mood. By wearing Pulsetto regularly to stimulate the vagal nerve, users can train their bodies and minds to maintain a more consistently relaxed state, reducing their risk for stress-related health problems.

The Pulsetto vagus nerve stimulation device and corresponding app, which comes with five stress-relieving stimulations, were designed by leading neuromodulation and sleep experts. The company is currently offering a month-long trial of the Pulsetto app which includes three extra stimulations, 11 unique guided meditations, 1200 positive affirmations, 54 breathing exercises, and more.

One spokesperson for the company said, "Our goal is to help 100 million people wake up every morning happier and healthier. We use the latest science to fight the modern world’s biggest problems - stress, anxiety, sleep disorders, and mental health issues. We master technology and use it to deliver the highest quality products so that our customers are always satisfied."

Interested parties can learn more about Pulsetto and purchase the vagus nerve stimulation device by visiting https://pulsetto.tech/products/meet-pulsetto

Contact Info:
Name: Agnė Ginaitė
Email: Send Email
Organization: Pulsetto
Address: 3 Aludarių gatvė, Vilnius, Vilniaus apskritis 01113, Lithuania
Website: https://pulsetto.tech/

Release ID: 89134115

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.

You May Also Be Interested In

• NNG and Dacia Offer Drivers OSM-Based Maps for Navigation
• Acer Launches Next-Gen E-Bikes at Eurobike 2024
• Parkinson’s Disease: A Digital Biomarker Platform for Differentiated Diagnosis